Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
Gastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/full |
id |
doaj-05bae95a57b44f3d9a7787c89fbb8530 |
---|---|
record_format |
Article |
spelling |
doaj-05bae95a57b44f3d9a7787c89fbb85302020-11-25T03:41:46ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2020-08-01710.3389/fmolb.2020.00203553175Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and TreatmentXiao-Jing Shi0Yongjun Wei1Boyang Ji2Boyang Ji3Laboratory Animal Center, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Academy of Medical Science, Zhengzhou University, Zhengzhou, ChinaSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou, ChinaDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, SwedenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, DenmarkGastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of gastric cancer development, and the discovery of novel diagnostic biomarkers and therapeutics are major goals in gastric cancer research. Here, we review recent progress in application of omics technologies in gastric cancer research, with special focus on the utilization of systems biology approaches to integrate multi-omics data. In addition, the association between gastrointestinal microbiota and gastric cancer are discussed, which may offer insights in exploring the novel microbiota-targeted therapeutics. Finally, the application of data-driven systems biology and machine learning approaches could provide a predictive understanding of gastric cancer, and pave the way to the development of novel biomarkers and rational design of cancer therapeutics.https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/fullgastric canceromicssystems biologydata integrationpersonalized medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiao-Jing Shi Yongjun Wei Boyang Ji Boyang Ji |
spellingShingle |
Xiao-Jing Shi Yongjun Wei Boyang Ji Boyang Ji Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment Frontiers in Molecular Biosciences gastric cancer omics systems biology data integration personalized medicine |
author_facet |
Xiao-Jing Shi Yongjun Wei Boyang Ji Boyang Ji |
author_sort |
Xiao-Jing Shi |
title |
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment |
title_short |
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment |
title_full |
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment |
title_fullStr |
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment |
title_full_unstemmed |
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment |
title_sort |
systems biology of gastric cancer: perspectives on the omics-based diagnosis and treatment |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Molecular Biosciences |
issn |
2296-889X |
publishDate |
2020-08-01 |
description |
Gastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of gastric cancer development, and the discovery of novel diagnostic biomarkers and therapeutics are major goals in gastric cancer research. Here, we review recent progress in application of omics technologies in gastric cancer research, with special focus on the utilization of systems biology approaches to integrate multi-omics data. In addition, the association between gastrointestinal microbiota and gastric cancer are discussed, which may offer insights in exploring the novel microbiota-targeted therapeutics. Finally, the application of data-driven systems biology and machine learning approaches could provide a predictive understanding of gastric cancer, and pave the way to the development of novel biomarkers and rational design of cancer therapeutics. |
topic |
gastric cancer omics systems biology data integration personalized medicine |
url |
https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/full |
work_keys_str_mv |
AT xiaojingshi systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment AT yongjunwei systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment AT boyangji systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment AT boyangji systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment |
_version_ |
1724528377511018496 |